These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1706590)

  • 41. The Vpr protein from HIV-1: distinct roles along the viral life cycle.
    Le Rouzic E; Benichou S
    Retrovirology; 2005 Feb; 2():11. PubMed ID: 15725353
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Functional role of human immunodeficiency virus type 1 vpu.
    Terwilliger EF; Cohen EA; Lu YC; Sodroski JG; Haseltine WA
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5163-7. PubMed ID: 2472639
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Construction and in vitro properties of HIV-1 mutants with deletions in "nonessential" genes.
    Gibbs JS; Regier DA; Desrosiers RC
    AIDS Res Hum Retroviruses; 1994 Apr; 10(4):343-50. PubMed ID: 8068414
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles.
    Karacostas V; Wolffe EJ; Nagashima K; Gonda MA; Moss B
    Virology; 1993 Apr; 193(2):661-71. PubMed ID: 7681610
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
    BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
    J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Construction and in vitro properties of SIVmac mutants with deletions in "nonessential" genes.
    Gibbs JS; Regier DA; Desrosiers RC
    AIDS Res Hum Retroviruses; 1994 May; 10(5):607-16. PubMed ID: 7917522
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Morphogenesis of human immunodeficiency virus type 1.
    Chatterjee S; Basak S; Khan NC
    Pathobiology; 1992; 60(4):181-6. PubMed ID: 1388714
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Virion instability of human immunodeficiency virus type 1 reverse transcriptase (RT) mutated in the protease cleavage site between RT p51 and the RT RNase H domain.
    Abram ME; Parniak MA
    J Virol; 2005 Sep; 79(18):11952-61. PubMed ID: 16140771
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biological characterization of human immunodeficiency virus type 1 and type 2 mutants in human peripheral blood mononuclear cells.
    Akari H; Sakuragi J; Takebe Y; Tomonaga K; Kawamura M; Fukasawa M; Miura T; Shinjo T; Hayami M
    Arch Virol; 1992; 123(1-2):157-67. PubMed ID: 1550494
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Coding sequences upstream of the human immunodeficiency virus type 1 reverse transcriptase domain in Gag-Pol are not essential for incorporation of the Pr160(gag-pol) into virus particles.
    Chiu HC; Yao SY; Wang CT
    J Virol; 2002 Apr; 76(7):3221-31. PubMed ID: 11884546
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cell-free HIV-1Zr6 vif mutants are defective in binding to peripheral blood mononuclear cells and in internalization.
    Nagashunmugam T; Friedman HM
    DNA Cell Biol; 1996 May; 15(5):353-61. PubMed ID: 8924209
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vpr is required for efficient Nef expression from unintegrated human immunodeficiency virus type 1 DNA.
    Poon B; Chang MA; Chen IS
    J Virol; 2007 Oct; 81(19):10515-23. PubMed ID: 17652391
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Growth ability of human immunodeficiency virus type 1 auxiliary gene mutants in primary blood macrophage cultures.
    Kawamura M; Ishizaki T; Ishimoto A; Shioda T; Kitamura T; Adachi A
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2427-31. PubMed ID: 8077944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complementation of integrase function in HIV-1 virions.
    Fletcher TM; Soares MA; McPhearson S; Hui H; Wiskerchen M; Muesing MA; Shaw GM; Leavitt AD; Boeke JD; Hahn BH
    EMBO J; 1997 Aug; 16(16):5123-38. PubMed ID: 9305653
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mutations in the protease gene of human immunodeficiency virus type 1 affect release and stability of virus particles.
    Park J; Morrow CD
    Virology; 1993 Jun; 194(2):843-50. PubMed ID: 8503189
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
    Mautino MR; Keiser N; Morgan RA
    J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutational analysis of the human immunodeficiency virus vpr open reading frame.
    Ogawa K; Shibata R; Kiyomasu T; Higuchi I; Kishida Y; Ishimoto A; Adachi A
    J Virol; 1989 Sep; 63(9):4110-4. PubMed ID: 2474678
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A complex human immunodeficiency virus type 1 A/G/J recombinant virus isolated from a seronegative patient with AIDS from Benin, West Africa.
    Baldrich-Rubio E; Anagonou S; Stirrups K; Lafia E; Candotti D; Lee H; Allain JP
    J Gen Virol; 2001 May; 82(Pt 5):1095-1106. PubMed ID: 11297684
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of HIV replication by capsid mutant C6b.
    Shimano R; Iida S; Fukumori T; Yamamoto Y; Kawamura M; Furuta RA; Adachi A
    Biochem Biophys Res Commun; 1998 Jan; 242(2):313-6. PubMed ID: 9446791
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Persistent infection with SIVmac chimeric virus having tat, rev, vpu, env and nef of HIV type 1 in macaque monkeys.
    Igarashi T; Shibata R; Hasebe F; Ami Y; Shinohara K; Komatsu T; Stahl-Hennig C; Petry H; Hunsmann G; Kuwata T
    AIDS Res Hum Retroviruses; 1994 Aug; 10(8):1021-9. PubMed ID: 7811533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.